DaVita HealthCare Partners is trading 5.2% down at $216.10 in after-hours trading following a sharp post-earnings reversal despite reporting better-than-expected results.
- The company reported Q2 2026 revenue of $3.554 billion and EPS of $4.02, both exceeding analyst estimates.
- The sell-off may reflect profit-taking or investor reaction to specific details shared during the earnings call.
- After-hours price action can be amplified by thinner liquidity compared to regular trading sessions.